Cefazolin Injection, Powder, For Solution
Product Images NDC 60505-6142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 60505-6142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2
This is a product description for a vial of Cefazolin for injection, containing 1 gram of Cefazolin with a sodium content of 48 mg. The recommended dosage for adults is 250mg to 1g every 6 to 8 hours for up to 10 days. The vial should be protected from light and stored at room temperature. To administer, add 25mL of sterile water for injection and shake well. The product is manufactured by Qi Pharmaceutical Co Ltd in China and distributed by Apotex Corp in Florida, USA. It is suitable for IV or IM use.*
Figure 3
The scanned text appears to be a product label for Cefazolin for Injection, USP. It is a medication intended for intramuscular or intravenous use, and is available in vials of 1 gram or 251 grams. The dosage ranges from 250 mg to 1 g, and it is recommended to store the medication at a temperature of 20-25°C. The medicine should be used immediately after reconstitution and the manufacturer is listed as ApoTex Corp.*
Figure 4
Figure 5
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.